Eli Lilly: The Party Is Not Over

Scott Olson/Getty Images News Context The world of software is being revolutionized by AI technology. The same thing happens in the pharmaceutical world, where new drugs to fight obesity are the driver of its transformation. It is a revolutionary medicine not only to get people thinner but also because obesity is the cause of a lot of diseases, from cardiovascular health problems to diabetes and cancer… Two companies are leading this space: Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY). I am interested in ...